Notably, both IFITM1 and IFIT1 are part of the interferon-related DNA damage resistance signature (IRDS) genes, which has been linked to the development of resistance to radiation therapy, chemotherapy, and immune checkpoint blockades in various cancers, and promotion tumor growth, metastasis and immune evasion [50, 51]. This evidence concerns the gene IFITM1 and neoplasm.